Galor Anat
In this database
8
2015 โ 2022
DB Citations
65
across indexed articles
h-index
โ
Not available
Total Citations
โ
Not available
8 articles in Glaucoma Journal Club
A Comparative Study of Central Corneal Epithelial, Stromal, and Total Thickness in Males With and Without Primary Open-Angle Glaucoma.
Individuals with glaucoma have lower CST and CCT measurements compared with individuals without glaucoma. An increased number of glaucoma medications were associated with lower thickness measurements.
Candida Endophthalmitis After Descemet Stripping Automated Endothelial Keratoplasty With Grafts From Both Eyes of a Donor With Possible Systemic Candidiasis.
Interface fungal keratitis and endophthalmitis due to infected donor corneal tissue is difficult to treat, and both recipients of grafts originating from the same donor are at risk of developing this challenging condition.
Role of Caspase-1 as a Biomarker of Ocular Surface Damage.
Caspase-1 levels were higher in the tears of individuals with ocular surface damage, suggesting its potential to be used as a biomarker and/or therapeutic target.
Clinicopathologic Correlations of Retrocorneal Membranes Associated With Endothelial Corneal Graft Failure.
Fibrocellular retrocorneal membrane proliferation may be associated with DSAEK failure in patients with previous glaucoma drainage device surgery.
Dry Eye Symptom Severity and Visual Field Reliability Metrics.
A total of 494 patients completed the 5-item Dry Eye Questionnaire and VF testing.
Supraciliary Microstent Revision in a Patient With Corneal Edema and Primary Open Angle Glaucoma: A Case Report.
Postoperatively, the implant was flush with the iris root with a patent lumen.
Refractive outcomes of combined cataract and glaucoma surgery.
Favorable refractive outcomes were achieved in the majority of patients despite the potential alteration of preoperative measurements and introduction of error into lens selection when using a combined approach.
Brimonidine allergy presenting as vernal-like keratoconjunctivitis.
Direct medication allergy and ocular surface disease are two distinct entities that often co-exist. Distinguishing between the two entities, sometimes by trial and error, is critical in the management of these patients.